Adrian Cabrera

Direktor/Vorstandsmitglied bei

Kiniciti

Finance

Consumer Services

Technology Services

Profil

Adrian Cabrera is currently a Principal at Welsh, Carson, Anderson & Stowe since 2022, and a Board Member at Kiniciti since 2021.
Mr. Cabrera completed undergraduate studies at Florida International University in 2013.

Aktive Positionen von Adrian Cabrera

Unternehmen	Position	Beginn
Welsh, Carson, Anderson & Stowe Welsh, Carson, Anderson & Stowe Investment ManagersFinance WCAS invest in companies located in the United States. The firm targets companies operating in the fields of healthcare and technology sectors. It provide financing for acquisitions and growth capital requirements.	Private Equity Investor	01.07.2019
Kiniciti Kiniciti Information Technology ServicesTechnology Services Develops resources, expertise and capital technology platform to help partner companies accelerate the advancement and adoption of cell & gene therapies	Direktor/Vorstandsmitglied	01.01.2021

Alle aktiven Positionen von Adrian Cabrera

Ausbildung von Adrian Cabrera

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Adrian Cabrera im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	3
Welsh, Carson, Anderson & Stowe Welsh, Carson, Anderson & Stowe Investment ManagersFinance WCAS invest in companies located in the United States. The firm targets companies operating in the fields of healthcare and technology sectors. It provide financing for acquisitions and growth capital requirements.	Finance
Florida International University Florida International University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kiniciti Kiniciti Information Technology ServicesTechnology Services Develops resources, expertise and capital technology platform to help partner companies accelerate the advancement and adoption of cell & gene therapies	Technology Services